Q&A with Mark Garner: The golden age of cancer research
Drug Discovery World
JULY 5, 2023
For example, in CAR-T-cell therapy, scientists can take T-cells from a patient and ex vivo (outside the body) genetically engineer them to effectively target and kill cancerous cells, then infuse them back in to the patient. Mark Garner, PhD., RA: Please can you tell us a bit more about your role at Agilent?
Let's personalize your content